Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 6 , Pages 598-603 , November 2009

Clinical outcome of combined immunotherapy with interferon-α and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma

  • Hideaki Miyake, M.D., Ph.D.

      Affiliations

    • Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-78-382-6155; fax: +81-78-382-6169
    • ,
  • Toshifumi Kurahashi, M.D., Ph.D.

      Affiliations

    • Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan
    • ,
  • Atsushi Takenaka, M.D., Ph.D.

      Affiliations

    • Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan
    • ,
  • Taka-aki Inoue, M.D., Ph.D.

      Affiliations

    • Department of Urology, Hyogo Cancer Center, Akashi, Japan
    • ,
  • Masato Fujisawa, M.D., Ph.D.

      Affiliations

    • Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan

Received 10 April 2008 ,Revised 17 July 2008 ,Accepted 22 July 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1078-1439(08)00180-4

doi: 10.1016/j.urolonc.2008.07.023

Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 6 , Pages 598-603 , November 2009

Article Tools

* Image Usage & Resolution